Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion type Assertion NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_head.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion description "[The addition of palbociclib to letrozole in this phase 2 study significantly improved progression-free survival in women with advanced oestrogen receptor-positive and HER2-negative breast cancer.A phase 3 trial is currently underway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_provenance.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion evidence source_evidence_literature NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_provenance.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion SIO_000772 25524798 NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_provenance.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion wasDerivedFrom befree-2016 NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_provenance.
- NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_assertion wasGeneratedBy ECO_0000203 NP1249518.RA0ijVOONqG2xrVEO7-hO3sUYYaTJvKIh5IQy8AjUNgZ0130_provenance.